Skip to main content
Equibles
WAY logo

WAY · Waystar Holding Corp.

Track WAY — free

Use WAY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about WAY

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.24 +0.99 (+3.92%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.63B
Shares
191.75M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$25.25 Open$24.98 Day$24.76–25.62 52W close$17.31–40.89 Avg vol 30d2.9M Short int13.6M · 7.1% float · 4.5d Short vol34% Last earningsJul 29, 2026 DataJun 2024–Aug 2026 Filing10-Q · Jul 29

Up next

Next earnings call
Nov 1, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 29, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.5 · calm Equity put/call 0.39
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −1%
      below
      Price vs 50-day avg +12%
      above
      RSI (14) 59
      neutral
      MACD trend Negative
      52-week position 34%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +21%
      trailing
      6-month return −2%
      trailing
      YTD return −23%
      this year
      Relative strength −16%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $23 › 200d $26 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +71 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.11% of float · ▼ -6.5% MoM · 4.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      302 holders — near 2-yr high, broad support
      Squeeze score 57
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +17%
      Y/Y
      EPS growth +569%
      Y/Y
      Valuation P/E 34.5
      below peers
      Buyback $200.0M
      authorized
      Balance sheet $1.4B
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 53%
      annualized · 1-yr
      Max drawdown −58%
      past year
      ATR 4.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 29, 2026
      Total revenue · full fiscal year 2026 Maintained $1.28B – $1.29B
      Apr 29, 2026 $1.27B – $1.29B changed to Jul 29, 2026 $1.28B – $1.29B
      prior FY $1.1B midpoint +16.9% Y/Y
      Adjusted EBITDA · full fiscal year 2026 Non-GAAP Maintained $535M – $545M
      Jun 30, 2026 $535M – $545M changed to Jul 29, 2026 $535M – $545M
      Non-GAAP net income · full fiscal year 2026 Non-GAAP Raised $322M – $340M
      Apr 29, 2026 $317M – $335M changed to Jul 29, 2026 $322M – $340M
      Diluted non-GAAP net income per share · full fiscal year 2026 Non-GAAP Raised $1.61 – $1.70
      Apr 29, 2026 $1.59 – $1.68 changed to Jul 29, 2026 $1.61 – $1.70
      Prior guidance period ended · from the 8-K filed Oct 29, 2025
      Total revenue · full fiscal year 2025 $1.09B – $1.09B
      Adjusted EBITDA · full fiscal year 2025 $451M – $455M
      Non-GAAP net income · full fiscal year 2025 $271M – $274M
      Diluted non-GAAP net income per share · full fiscal year 2025 $1.46 – $1.47
      Guided vs delivered · last 1 settled
      Total revenue full fiscal year 2025
      guided $1.09B – $1.09B
      $1.1B Beat +0.9%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 5 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −1% Neutral
      Price vs 50-day avg
      +12% Bullish
      RSI (14)
      59 Neutral
      MACD trend
      Negative Bearish
      52-week position
      34% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $23 › 200d $26 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +71 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.11% of float · ▼ -6.5% MoM · 4.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      302 holders — near 2-yr high, broad support
      Price context
      position in its 52-week range
      Range low $17 Now $25 · 34% Range high $41
      vs 200-day avg -1% vs 50-day avg +12%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Net income 134.79M
      +80.68M Interest expense, net
      +60.29M Income tax expense
      +156.66M Depreciation and amortization
      +49.04M Stock-based compensation expense
      +23.8M Acquisition and integration costs
      +1.99M Asset and lease impairments
      +2.81M Costs related to amended debt agreements
      +1.47M IPO and Secondary Offering expenses
      +2.45M Other
      = Adjusted EBITDA 513.98M
      Annual gross claims $2.4T annually —
      Clients 30,000 as stated in About Waystar —
      Healthcare payment transactions 7.5B annually —
      Net revenue retention rate (NRR) 108% Q2 2026 —
      Patient revenue $87.9M Q2 2026 —
      Provider revenue $231.8M Q2 2026 —
      Trailing Twelve Months Adjusted EBITDA non-GAAP 513.98M TTM ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Net cash provided by operating activities 59.41M
      +20.61M Interest paid
      -16.11M Purchase of PP&E and capitalization of internally developed software costs
      = Unlevered free cash flow 63.91M
      Cost of revenue (exclusive of depreciation and amortization expenses), adjusted non-GAAP 95.46M Three months ended March 31, 2026 —
      Depreciation and amortization, adjusted non-GAAP 6.98M Three months ended March 31, 2026 —
      General and administrative, adjusted non-GAAP 21.2M Three months ended March 31, 2026 —
      Income tax expense, adjusted non-GAAP 26.61M Three months ended March 31, 2026 —
      Net debt non-GAAP 1.32B March 31, 2026 —
      Research and development, adjusted non-GAAP 15.56M Three months ended March 31, 2026 —
      Sales and marketing, adjusted non-GAAP 46.25M Three months ended March 31, 2026 —
      Non-GAAP net income/(loss) per share - Diluted non-GAAP $1.42 Twelve months ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      WAY
      Waystar Holding Corp.
      this stock
      		$4.63B -22.9% +16.5% 34.5 7.1%
      VEEV
      Veeva Systems Inc
      		 $39.78B +26.4% +28.1% 40.2 3.6%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      TEM
      Tempus AI, Inc.
      		 $12.36B +19.7% +83.4% — 16.6%
      BTSG
      BrightSpring Health Services, Inc.
      		 $12.25B +62.6% +28.2% 37.5 4.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      302
      % held
      110.9%
      Net QoQ
      +6.7M sh
      Top holder
      EQT Fund Management S.a r…
      Held Float
      View
      Held by Funds
      Fund positions
      347
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      13.6M
      Days to cover
      4.5d
      Change
      -946.8K sh
      View
      Short Volume
      Short vol %
      34%
      As of
      Aug 27, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      31
      Value
      $717
      As of
      Jul 28, 2026
      View
      Off-Exchange
      Off-exchange %
      40.3%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $1.1B
      Net income (FY)
      $112.1M
      EPS diluted
      $0.61
      View
      Buybacks
      Authorized
      $200.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 29, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $13.0M
      Shares
      518.2K
      Filed
      Aug 14, 2026
      View
      Exempt Offerings
      Offering
      $620.8M
      Filed
      Oct 10, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 29, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      WAY +1.7% +20.6% -1.8% +19.6% -22.9%
      SPY +1.1% +4.0% +14.7% +3.2% +13.1%
      vs SPY +0.5% +16.6% -16.5% +16.4% -36.0%

      Capital returns

      Buyback program · as of May 19, 2026
      Authorized
      $200.00M
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1990354 CUSIP 946784105 13F (30d) 253 filings 251 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)